CN105434947A - Traditional Chinese medicine bag for treating prostatitis - Google Patents
Traditional Chinese medicine bag for treating prostatitis Download PDFInfo
- Publication number
- CN105434947A CN105434947A CN201510986918.2A CN201510986918A CN105434947A CN 105434947 A CN105434947 A CN 105434947A CN 201510986918 A CN201510986918 A CN 201510986918A CN 105434947 A CN105434947 A CN 105434947A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- rhizoma
- complex
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 201000007094 prostatitis Diseases 0.000 title claims abstract description 19
- 238000010438 heat treatment Methods 0.000 claims abstract description 11
- 239000004863 Frankincense Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 5
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 9
- 241000717739 Boswellia sacra Species 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 241000221022 Manihot Species 0.000 claims description 6
- 241001057584 Myrrha Species 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 229940052810 complex b Drugs 0.000 claims description 6
- 235000005739 manihot Nutrition 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 14
- 238000011282 treatment Methods 0.000 abstract description 13
- 235000013399 edible fruits Nutrition 0.000 abstract 4
- 244000061520 Angelica archangelica Species 0.000 abstract 2
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 2
- 240000004507 Abelmoschus esculentus Species 0.000 abstract 1
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 240000007171 Imperata cylindrica Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 241000972673 Phellodendron amurense Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 241000245665 Taraxacum Species 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 description 11
- 230000027939 micturition Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 230000008506 pathogenesis Effects 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 210000003708 urethra Anatomy 0.000 description 4
- 210000000436 anus Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 208000013507 chronic prostatitis Diseases 0.000 description 3
- 239000011229 interlayer Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 210000001113 umbilicus Anatomy 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000032023 Signs and Symptoms Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 206010018866 Haematospermia Diseases 0.000 description 1
- 208000008982 Hemospermia Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010072353 Painful ejaculation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000013210 hematogenous Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 210000004779 membrane envelope Anatomy 0.000 description 1
- 230000005184 men's health Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 description 1
- 229960001289 prazosin Drugs 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 229940072254 proscar Drugs 0.000 description 1
- 210000003689 pubic bone Anatomy 0.000 description 1
- 230000004895 regional blood flow Effects 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- VCKUSRYTPJJLNI-UHFFFAOYSA-N terazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1CCCO1 VCKUSRYTPJJLNI-UHFFFAOYSA-N 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OOGJQPCLVADCPB-HXUWFJFHSA-N tolterodine Chemical compound C1([C@@H](CCN(C(C)C)C(C)C)C=2C(=CC=C(C)C=2)O)=CC=CC=C1 OOGJQPCLVADCPB-HXUWFJFHSA-N 0.000 description 1
- 229960004045 tolterodine Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- BDIAUFOIMFAIPU-UHFFFAOYSA-N valepotriate Natural products CC(C)CC(=O)OC1C=C(C(=COC2OC(=O)CC(C)C)COC(C)=O)C2C11CO1 BDIAUFOIMFAIPU-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229940091251 zinc supplement Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/009—Sachets, pouches characterised by the material or function of the envelope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine bag for treating prostatitis, which comprises a heating bag and a traditional Chinese medicine layer. The traditional Chinese medicine layer is prepared from the following raw materials in parts by weight: 30 parts of Herba Patriniae, 20 parts of rhubarb, 10 parts of phellodendron bark, 10 parts of dodder, 10 parts of Japanese sweetflag, 10 parts of frankincense, 10 parts of myrrh, 10 parts of safflower, 10 parts of okra, 10 parts of wolfberry fruit, 15 parts of taraxacum, 15 parts of schisandra fruit, 15 parts of mulberry fruit, 15 parts of licorice, 15 parts of toosendan fruit, 15 parts of plantain, 15 parts of herba houttuyniae, 8 parts of angelica, 8 parts of tuckahoe, 8 parts of Chinese yam, 8 parts of teasel root, 8 parts of angelica, 8 parts of rhizoma atractylodis, 5 parts of cogongrass rhizome and 5 parts of cinnamon. The product has obvious and stable treatment effect on prostatitis, and has wide application prospects.
Description
Technical field
The invention belongs to Chinese medicine technical field, concrete, relate to a kind of for prostatitic pharmaceutical composition, more specifically, the present invention relates to a kind of prostatitis Chinese medicine precious.
Background technology
Prostatitis is a kind of adult male urology department commonly encountered diseases, because the current understanding to pathogenic factor is still unclear, adds its more special anatomical structure and is multiplely born in sexual activity many-sided reason such as crowd frequently, making the touching difficulty of its treatment more.The patient that usually can see chronic prostatitis in life repeatedly cures, the situation all can not effected a radical cure.Most patients with chronic prostatitis therapeutic effect is unsatisfied with in the world at present, and common method has antibiotic therapy, naturopathy, stagnant dose of alpha-receptor group, repeatedly massage of prostate, muscle relaxant, vegetalitas Chinese medicine etc.Due to the particularity of prostate anatomy physiological location, outer by lipid envelope, antibiotic medicine ion is difficult to penetrate, and curative effect is poor; Though direct drug injection thing iontophoresis or per urethra directly rapid-action against filling method curative effect, operation inconvenience, easily cause bleeding, cause double infection and form rhabdion, seondary effect is many.In addition the employing zinc supplement method also had and estrin treatment.
External a large amount of alpha-blocking agent that uses reduces bladder outlet resistance and urethral orifice closing presure, as hytrin, and prazosin etc., also useful 5α-reductase suppresses the generation of two hydrogen testosterone in human body, as proscar, 5-fluorouracil etc.Said medicine curative effect still can, but price is all expensive and comparatively large on blood pressure impact, still can not promote.Domestic and international multiple western medicine therapy is analyzed on the whole, and curative effect is not good enough, and side effect is more, especially obvious to the patient suffering from some other complication.
Prostatitic etiology is very complicated, although the pathogenesis numerous to it has had the understanding of certain degree, does not all have breakthrough.Think that chronic prostatitis may be constitutional due to prostate and surrounding tissue organ, muscle and nerve or secondary disease at present, even after these diseases have been cured or thoroughly eradicated, the infringement that its () is caused and pathological change are still continuing to work independently, the center of its cause of disease may be infect, the combined effect of neuron-muscular activity at the bottom of the basin of inflammation and exception.
Prostatitic complicated symptoms is various, sometimes easily obscures with simple neurasthenia, therapeutic effect is not felt quite pleased, treatment standard disunity.Urethral stimulant can be had to levy from clinical manifestation patient, frequent micturition, urgent micturition, urethra causalgia, there are mucus, haircuts or purulent secretion in early morning urine road junction, urine muddiness or stool Posterior urethral mouth adularescent liquid flow out, Posterior urethral, perineum and anus are uncomfortable, sometimes penis, testis and pars inguinalis pain, with the symptom of painful ejaculation, hemospermia, premature ejaculation, sexual impotence and weak, dizzy, insomnia and the autonomic nervous dysfunction such as melancholy.
Motherland's medical science thinks that prostatitis belongs to the categories such as " stranguria caused by overstrain ", " excessive in vain ", " essence is turbid " of Chinese medicine.Pathogenesis is addicted to cigarette, wine, pungent, delicious food savoury, so that impairing the spleen and stomach, makes raw damp and hot, the multiple abscess part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels; Sexual life is unclean, directly contaminates, and Shi Re Bing Pian drives in the wrong direction, so that stations the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels; Society and environmental factors, the impacts such as medium stimulation, libido can not get normal catharsis, frequent masturbation, sexual overstrain, bears essence not let out, and causes prostate repeatedly congested, accumulates to make poison for a long time, hinders in meridians; Or feelings will is smooth, depressed rage impairing the liver, stagnation of QI due to depression of the liver, for a long time then hematogenous blockage and cause coagulation of QI-blood, coagulation of QI-blood increases the weight of again Shi Re Bing Pian and is formed.
Prior art prescriptions of Chinese medicine shortage is dialectical, and treatment cycle is long, and property of suiting the medicine to the illness is strong, and curative effect is not obvious, even also can bring side effect to patient, increases patient suffering, from natural drug, find effective, safe drugs, has become the problem generally needing to solve.
Summary of the invention
The present invention is with reference to the motherland medical science invaluable experience to the pathogenetic understanding of prostatitis and treatment, consult existing reasonable formula, determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, according to Chinese Pharmacopoeia and pharmacology compatibility, push away Chen Zhixin gain to some extent, determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs is the core theory of Chinese medicine disease always, how to take into account secondary pathogenesis for main pathogenesis medication simultaneously, taking into account the treatment of general character and individual character, thus at utmost embody intension and the extension of Chinese traditional treatment disease, is a realistic problem of Chinese patent medicine compatibility.Theoretical by Chinese medical discrimination, cause the Etiological pathogenesis of this disease to be that Shi Re Bing Pian drives in the wrong direction, so that station the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, prostate is repeatedly congested, accumulates and makes poison for a long time, hinders in meridians.Inventor by the research to Chinese medicine, and in conjunction with dialectical demonstration, collects the length of many families in many ways, seek therapeutic regimen, from motherland's medical treasure-house, filter out promoting the flow of QI in the collateral by warming the meridian, the natural component of wind dispelling cold expelling, by theory of Chinese medical science prescription, skim the cream off milk, be meticulously mixed with in conjunction with Traditional Chinese Medicine technology of the present invention precious for prostatitic prostatitis Chinese medicine, relative to Western medicine, to prostatitis treating successful, stablize, useful men's health.
For realizing the object of the invention, the technical solution used in the present invention is as follows:
A kind of for prostatitic compositions, it comprises heating bag and Chinese traditional medicine layer, it is characterized in that described Chinese traditional medicine layer is prepared by the raw material of following weight proportioning and obtains:
Herba Patriniae 30 parts, Radix Et Rhizoma Rhei 20 parts, Cortex Phellodendri 10 parts, Semen Cuscutae 10 parts, Rhizoma Acori Graminei 10 parts,
Olibanum 10 parts, Myrrha 10 parts, 10 parts, Flos Carthami, Flos abelmoschi manihot 10 parts, Fructus Lycii 10 parts,
Herba Taraxaci 15 parts, Fructus Schisandrae Chinensis 15 parts, Fructus Mori 15 parts, 15 parts, Radix Glycyrrhizae, Fructus Toosendan 15 parts,
Herba Plantaginis 15 parts, Herba Houttuyniae 15 parts, the Radix Angelicae Dahuricae 8 parts, 8 parts, Poria, Rhizoma Dioscoreae 8 parts,
Radix Dipsaci 8 parts, Radix Angelicae Sinensis 8 parts, Rhizoma Atractylodis 8 parts, Rhizoma Imperatae 5 parts, Cortex Cinnamomi 5 parts.
The preparation method of described Chinese traditional medicine layer is:
1) each crude drug is taken, for subsequent use;
2) get Herba Patriniae, Radix Et Rhizoma Rhei, Cortex Phellodendri, Semen Cuscutae, Rhizoma Acori Graminei, Olibanum, Myrrha, Flos Carthami pulverized 100 mesh sieves and obtain complex A;
3) get Flos abelmoschi manihot, water intense fire that Fructus Schisandrae Chinensis, Fructus Mori, Fructus Toosendan, the Radix Angelicae Dahuricae, Poria, Radix Angelicae Sinensis, Rhizoma Imperatae, Cortex Cinnamomi add 4 times of weight boils, then slow fire boiling 1 hour, collecting by filtration filtrate and filtering residue; In filtering residue, add water, not have filtering residue to be as the criterion, intense fire boiled, then slow fire boiling 30 minutes, collecting by filtration filtrate; Merge above-mentioned twice filtrate, after cooling, be condensed into the extractum that density is 1.2g/ml; After 80 DEG C of oven dry, be ground into powder, be complex B;
4) the 70%(volume ratio that residual components adds is got) soak with ethanol 0.5-1.5 hour, extracts twice, each 1-2 hour, merge extractive liquid, filters, be condensed into the extractum that relative density is 1.2g/ml, crushed after being dried, obtain complex C;
5) by complex A, complex B, complex C mixing and stirring, load in ventilative non-woven bag, every bag of 6-10g and get final product.
The component of medicine of the present invention all adopts natural raw material of Chinese medicine, and its preparation is easy, and medicine source is extensive, with low cost, it follows the prescriptions principle of the traditional Chinese medical science, and all medicines share, bring out the best in each other, monarch respectively executes its effect, wears heating bag and uses, fill in crotch interlayer at the bottom of underwear by this prostatitis Chinese medicine treasured, heating bag is towards human body, and Chinese medicine bag is outside, disposablely place 10-12 hour, more renew bag, sleep, walking, sitting all can use, be particularly suitable for sitting crowd, as deskman, driver etc.Through clinical practice checking, it is reliably evident in efficacy, mild in medicine property, has a extensive future.
Detailed description of the invention
Embodiment 1
Be used for a prostatitic prostatitis Chinese medicine treasured, it comprises heating bag and Chinese traditional medicine layer, it is characterized in that described Chinese traditional medicine layer is prepared by the raw material of following weight proportioning and obtains:
Herba Patriniae 30 parts, Radix Et Rhizoma Rhei 20 parts, Cortex Phellodendri 10 parts, Semen Cuscutae 10 parts, Rhizoma Acori Graminei 10 parts,
Olibanum 10 parts, Myrrha 10 parts, 10 parts, Flos Carthami, Flos abelmoschi manihot 10 parts, Fructus Lycii 10 parts,
Herba Taraxaci 15 parts, Fructus Schisandrae Chinensis 15 parts, Fructus Mori 15 parts, 15 parts, Radix Glycyrrhizae, Fructus Toosendan 15 parts,
Herba Plantaginis 15 parts, Herba Houttuyniae 15 parts, the Radix Angelicae Dahuricae 8 parts, 8 parts, Poria, Rhizoma Dioscoreae 8 parts,
Radix Dipsaci 8 parts, Radix Angelicae Sinensis 8 parts, Rhizoma Atractylodis 8 parts, Rhizoma Imperatae 5 parts, Cortex Cinnamomi 5 parts.
The preparation method of described Chinese traditional medicine layer is:
1) each crude drug is taken, for subsequent use;
2) get Herba Patriniae, Radix Et Rhizoma Rhei, Cortex Phellodendri, Semen Cuscutae, Rhizoma Acori Graminei, Olibanum, Myrrha, Flos Carthami pulverized 100 mesh sieves and obtain complex A;
3) get Flos abelmoschi manihot, water intense fire that Fructus Schisandrae Chinensis, Fructus Mori, Fructus Toosendan, the Radix Angelicae Dahuricae, Poria, Radix Angelicae Sinensis, Rhizoma Imperatae, Cortex Cinnamomi add 4 times of weight boils, then slow fire boiling 1 hour, collecting by filtration filtrate and filtering residue; In filtering residue, add water, not have filtering residue to be as the criterion, intense fire boiled, then slow fire boiling 30 minutes, collecting by filtration filtrate; Merge above-mentioned twice filtrate, after cooling, be condensed into the extractum that density is 1.2g/ml; After 80 DEG C of oven dry, be ground into powder, be complex B;
4) the 70%(volume ratio that residual components adds is got) soak with ethanol 0.5 hour, extract twice, each 1 hour, merge extractive liquid, filter, be condensed into the extractum that relative density is 1.2g/ml, crushed after being dried, obtain complex C;
5) by complex A, complex B, complex C mixing and stirring, load in ventilative non-woven bag, every bag of 10g and get final product.
Described heating bag is commercially available common heating bag, and Chinese medicine of the present invention is precious disposable places 10-12 hour, more renews bag, and sleep, walking, sitting all can use, and are particularly suitable for sitting crowd, as deskman, driver etc.
Heating bag promotes temperature, and regional blood circulation at the bottom of prostate basin increases, and improves local blood supply.
Chinese medicine bag volatilizees quickening under heating bag effect, local skin heat after blood circulation improve, absorb Chinese medicine ability and strengthen, enhance the effect of blood circulation promoting and blood stasis dispelling, damp eliminating temperature compensation.The all right moisture absorption of Powdered medicated powder is effective especially to improving perineal position humidity, scrotal pruritus.Chinese medicine bag and heating bag synergism, strengthen mutually.
Embodiment 2
Acute toxicity test: Chinese traditional medicine layer embodiment 1 prepared is affixed on the complete and damaged skin of rabbit with 10 times amount of external application consumption at every turn, and multiple dosing is all non-stimulated, to guinea pig skin without anaphylaxis, and has no any toxicity.
Long term toxicity test: Chinese medicine embodiment 1 prepared is precious is affixed on de-plucked rabbit back (two lung projection back) respectively at every turn with 5 of external application amount times, 10 times amount, and each subsides 4 hours, paste 1 every day, continuous 2 weeks.Its hemogram, lung, Liver and kidney function are observed, finds no toxic action; The toxic infringements of organ such as the heart, liver, spleen, lung, kidney are not found through pathological section.Therefore point out clinical recommended drug dosage use safety.
Pathology results shows, and of the present invention group of basement membrane is substantially complete, all has part adenomatosis, and the uneven hypertrophy of part lumen of gland cell, in multilayer structure.
Embodiment 3
Meet diagnosis 122 routine prostatitis patients are divided into treatment group and matched group at random, often organize 61 people.
Diagnostic criteria
Male's limb is soft weak, physical weakness, paruria---frequent micturition, urgent micturition, urethra scorching hot, acraturesis, urine retention; Urethral orifice " drips white ", prostate region---perineal position, anus, pubis lower regions pain.
Administrated method
During clinical experiment, withdraw other medicines and health nutrient.Give prostatitis of the present invention Chinese medicine precious, crotch at the bottom of underwear is designed to pocket-like interlayer, can holds pocket, Chinese medicine treasured of the present invention is placed in interlayer, and every day one pastes.
Matched group gives tolterodine conventional therapy.
Curative effect determinate standard:
1, effective: body constitution strengthens, with it energetically; Frequent micturition, urgent micturition, urethra scorching hot, urine retention are obviously alleviated; Urethral orifice " drips in vain " phenomenon obviously to be reduced or disappears, and prostate region pain is significantly alleviated.
2, effective: body constitution strengthens, with it energetically; Frequent micturition, urgent micturition, urine retention are alleviated to some extent, and prostate region pain alleviates to some extent.
3, invalid: disease is unchanged.
Conclusion, two groups of comparitive study are in table 1.
Table 1: efficacy result
| Group | Number of cases | Effective | Effectively | Invalid | Total effective rate |
| Treatment group | 61 | 30 | 26 | 5 | 91.8% |
| Matched group | 61 | 13 | 33 | 15 | 75.4％ |
Treatment group is matched group significant difference comparatively.
Embodiment 4
Model case
Thank certain, 33 years old, perineal position testis and bilateral inguinal place pain are done swollen, and dysurea is scorching hot, and the heeltap is unclean, has after an action of the bowels and drips white phenomenon, with soreness of the waist and knees, spiritlessness and weakness.Anus refers to inspection: the enlargement of prostate I degree, and quality is comparatively hard, gives Chinese medicine treasured of the present invention and once uses 10 hours, can slow down and eliminate dampness of scrotum pruritis, give one month, and patients symptomatic disappears, and prostate quality is soft, and without tenderness, follow-up has no recurrence half a year.
What more than enumerate is only best specific embodiment of the present invention.Obviously, the invention is not restricted to above embodiment, many distortion can also be had.All distortion that those of ordinary skill in the art can directly derive from content disclosed by the invention or associate, all should think protection scope of the present invention.
Claims (3)
1. a prostatitis Chinese medicine is precious, and it comprises heating bag and Chinese traditional medicine layer, it is characterized in that, described Chinese traditional medicine layer is prepared by the raw material of following weight proportioning and obtains:
Herba Patriniae 30 parts, Radix Et Rhizoma Rhei 20 parts, Cortex Phellodendri 10 parts, Semen Cuscutae 10 parts, Rhizoma Acori Graminei 10 parts,
Olibanum 10 parts, Myrrha 10 parts, 10 parts, Flos Carthami, Flos abelmoschi manihot 10 parts, Fructus Lycii 10 parts,
Herba Taraxaci 15 parts, Fructus Schisandrae Chinensis 15 parts, Fructus Mori 15 parts, 15 parts, Radix Glycyrrhizae, Fructus Toosendan 15 parts,
Herba Plantaginis 15 parts, Herba Houttuyniae 15 parts, the Radix Angelicae Dahuricae 8 parts, 8 parts, Poria, Rhizoma Dioscoreae 8 parts,
Radix Dipsaci 8 parts, Radix Angelicae Sinensis 8 parts, Rhizoma Atractylodis 8 parts, Rhizoma Imperatae 5 parts, Cortex Cinnamomi 5 parts.
2. Chinese medicine according to claim 1 is precious, and it is characterized in that, the preparation method of described Chinese traditional medicine layer comprises the steps:
1) each crude drug is taken, for subsequent use;
2) get Herba Patriniae, Radix Et Rhizoma Rhei, Cortex Phellodendri, Semen Cuscutae, Rhizoma Acori Graminei, Olibanum, Myrrha, Flos Carthami, mixing, pulverized 100 mesh sieves and obtain complex A;
3) get Flos abelmoschi manihot, Fructus Schisandrae Chinensis, Fructus Mori, Fructus Toosendan, the Radix Angelicae Dahuricae, Poria, Radix Angelicae Sinensis, Rhizoma Imperatae, Cortex Cinnamomi, mixing, the water intense fire adding 4 times of weight boils, then slow fire boiling 1 hour, collecting by filtration filtrate and filtering residue; In filtering residue, add water, not have filtering residue to be as the criterion, intense fire boiled, then slow fire boiling 30 minutes, collecting by filtration filtrate; Merge twice filtrate, after cooling, be condensed into the extractum that density is 1.2g/ml; After 80 DEG C of oven dry, be ground into powder, be complex B;
4) get surplus stock, mixing, 70% soak with ethanol added 1 hour, extract twice, each 1-2 hour, merge extractive liquid, filter, be condensed into the extractum that relative density is 1.2g/ml, crushed after being dried, obtain complex C;
5) by complex A, complex B and complex C mixing and stirring, to obtain final product.
3. the application of Chinese medicine treasured in prostatitis described in claim 1-2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510986918.2A CN105434947A (en) | 2015-12-26 | 2015-12-26 | Traditional Chinese medicine bag for treating prostatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510986918.2A CN105434947A (en) | 2015-12-26 | 2015-12-26 | Traditional Chinese medicine bag for treating prostatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105434947A true CN105434947A (en) | 2016-03-30 |
Family
ID=55545872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510986918.2A Pending CN105434947A (en) | 2015-12-26 | 2015-12-26 | Traditional Chinese medicine bag for treating prostatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105434947A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110613177A (en) * | 2019-11-01 | 2019-12-27 | 陕西理工大学 | Chinese herbal medicine underpants for preventing and treating male prostate and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1682810A (en) * | 2005-02-22 | 2005-10-19 | 黄资源 | External application powder for treating prostate diseases |
| CN101732660A (en) * | 2009-12-25 | 2010-06-16 | 卢速江 | Chinese medicinal preparation for treating prostate disease and preparation method thereof |
| CN103690614A (en) * | 2013-12-30 | 2014-04-02 | 周艳艳 | Traditional Chinese medicine for treating prostatitis |
-
2015
- 2015-12-26 CN CN201510986918.2A patent/CN105434947A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1682810A (en) * | 2005-02-22 | 2005-10-19 | 黄资源 | External application powder for treating prostate diseases |
| CN101732660A (en) * | 2009-12-25 | 2010-06-16 | 卢速江 | Chinese medicinal preparation for treating prostate disease and preparation method thereof |
| CN103690614A (en) * | 2013-12-30 | 2014-04-02 | 周艳艳 | Traditional Chinese medicine for treating prostatitis |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110613177A (en) * | 2019-11-01 | 2019-12-27 | 陕西理工大学 | Chinese herbal medicine underpants for preventing and treating male prostate and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103028091B (en) | Traditional Chinese medicine composition for treating damp heat of liver and gallbladder | |
| CN101869665B (en) | Chinese medicinal composition for treating necrospermia, asthenospermia oligospermia, or aspermatism | |
| CN102058715B (en) | Chinese medicine preparation for treating chronic prostatitis and preparation method thereof | |
| CN102526677B (en) | Chinese medicine foot-massage composition for treating common cold due to wind-cold | |
| CN103536852A (en) | Pharmaceutical composition for treating mental disease and use thereof | |
| CN102085299B (en) | Chinese patent medicine for treating prostatitis and preparation method thereof | |
| CN103316145B (en) | A kind of Traditional Chinese medicine foot soaping liquid and preparation method for the treatment of lower limb distending pain | |
| CN101361949B (en) | Traditional Chinese medicine for treating gynaecologic emmeniopathy | |
| CN103830527B (en) | One treats prostatitic preparation | |
| CN102805844B (en) | Medicine for treating liver cancer | |
| CN105497788A (en) | Medicinal preparation for prostatitis | |
| CN105434947A (en) | Traditional Chinese medicine bag for treating prostatitis | |
| CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
| CN104606514A (en) | Traditional Chinese medicine composition for treating kidney deficiency type tinnitus | |
| CN103071079B (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
| CN105362682A (en) | External-use medicine for treating hypomenorrhea | |
| CN104667050A (en) | Traditional Chinese medicine for treating insomnia | |
| CN104258275A (en) | Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis | |
| CN104547709A (en) | Chinese medicinal composition for treating meniere disease as well as preparation method and application thereof | |
| CN104398949A (en) | Traditional Chinese medicine oral liquid for treating prostatitis | |
| CN104352994A (en) | Pharmaceutical preparation for sexual dysfunction | |
| CN103656063A (en) | Medicine for treating chronic prostatitis | |
| CN104547434B (en) | One treats chronic prostatitis Chinese medicine composition | |
| CN106266962A (en) | A kind of medicament composing prescription for the nursing of puerpera's postpartum depression and preparation method | |
| CN105816724A (en) | Traditional Chinese medicine composition for treating female hypersexuality |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160330 |
|
| RJ01 | Rejection of invention patent application after publication |